British Columbia marked the 10th anniversary of its declaration of a public health emergency in response to a toxic drug crisis that has claimed nearly 19,000 lives since early 2016. The emergency, declared on April 14, 2016, by then-provincial health officer Perry Kendall, was triggered by a dramatic rise in overdose deaths fueled largely by the infiltration of illicit fentanyl into the drug supply.

The declaration enabled enhanced data sharing and rapid expansion of harm-reduction measures, including supervised consumption sites, drug checking, and naloxone distribution programs. Since then, the province has increased the number of supervised consumption and overdose prevention sites from one to 58 community-based locations and nine hospital sites. Naloxone kits are now distributed at a rate exceeding 400,000 per year, and paramedics and first responders regularly manage overdoses across both urban and rural areas.

Despite these efforts, overdose deaths have remained high, peaking with more than 2,500 fatalities annually and over 40,000 recorded overdoses in 2024 alone. The complexity of the illicit drug market has grown, with fentanyl replacing heroin as the dominant opioid, compounded by the presence of benzodiazepines and other sedatives that complicate treatment and response efforts. Drug adulteration has become increasingly common, sometimes resulting in users unknowingly ingesting substances with multiple compounds.

Health officials and experts gathered in Victoria to reflect on the past decade, acknowledging both progress and setbacks. Provincial Health Officer Bonnie Henry expressed disappointment that some of her recommendations, including the expansion of prescribed safer supply programs and decriminalization of personal drug possession, were retracted due to political pressures and public concerns. She emphasized the need to continue exploring these approaches safely and addressing public safety and stigma.

Bernie Pauly, a researcher specializing in substance use, highlighted failures in implementation largely stemming from moral panic and misinformation, noting that drug decriminalization efforts suffered from insufficient public education and lack of comprehensive support services such as housing and mental health care. First Nations Health Authority’s Chief Medical Officer Nel Wieman underscored the disproportionate impact of the crisis on Indigenous communities but maintained hope for improvement.

Conversely, some political figures criticized the provincial government's approach. The B.C. Conservative critic for mental health and addictions characterized the government's support for safe supply and decriminalization as ideological missteps that have exacerbated the crisis, while an independent MLA expressed doubts about the government's capacity to fund necessary programs amid a sizable budget deficit.

Policy experts note that the province has tried a wide array of interventions—ranging from harm reduction to treatment and enforcement—but without a fully coordinated and sustained strategy. Attempts to decriminalize drug possession for a three-year period were ultimately reversed amid public backlash linked to increased visible drug use and disorder. The government is now shifting toward expanding involuntary treatment and boosting addiction treatment capacity, which has only modestly increased since 2016.

The toxic drug emergency remains a complex issue requiring a multifaceted approach that balances prevention, harm reduction, treatment, and enforcement. While progress has been made, British Columbia continues to grapple with the evolving nature of its illicit drug supply and societal challenges tied to housing, mental health, and stigma, underscoring the need for ongoing adaptation of strategies in response to the crisis.